In this issue (1), Halsey and Salmon discuss reasons for the continued occurrence of measles in the United States despite the availability of highly effective vaccines.
Before the development of live attenuated vaccines in the 1960s and 1970s, measles was a ubiquitous and feared infection in children that could result in serious complications and death. In 1928, Cooke (2) described in detail the only prophylactic approach available at that time-passive immunization of high-risk children exposed to measles by intramuscular injection of serum from patients who had recently had the disease.
